HI-PEITHONCT04790370
Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
The 50 most recent of 61 versions: 34 with changes below, 16 re-verified with no change. See every version on ClinicalTrials.gov ↗
Notable Results posted: Nov 16, 2026 Show 5 more changesShow less
- Primary endpoint(s) modified
- Eligibility criteria expanded, about 35 words
- Trial completed
- Study completion date changed from estimate of Aug 2026 to Aug 18, 2026
- Publications: details revised at 26 of 29 entries
- Minor Study sites: 61 to 60v56
- Minor Study sites: 62 to 61v55
- Notable Eligibility criteria revised
- Study sites: 63 to 62
- Minor Primary completion date changed from estimate of Aug 2025 to Jul 31, 2025v51
Show 29 earlier versionsHide 29 earlier versions
- Minor Trial status: Recruiting to Active, Not Recruiting
- Study sites: 72 to 63
- Minor Site details revised at 7 of 72 sitesv47
- Minor Site details revised at 3 of 72 sitesv46
- Minor Site details revised at 1 of 72 sitesv45
- Minor Site details revised at 3 of 72 sitesv44
- Minor Site details revised at 1 of 72 sitesv43
- Minor Site details revised at 2 of 72 sitesv42
- Minor Site details revised at 4 of 72 sitesv41
- Minor Site details revised at 1 of 72 sitesv40
- Minor Site details revised at 1 of 72 sitesv39
- Minor Site details revised at 2 of 72 sitesv38
- Minor Study sites: 70 to 72v36
- Minor Study sites: 64 to 70v35
- Minor Study sites: 65 to 64v34
- Minor Site details revised at 2 of 65 sitesv33
- Notable Primary completion date: Jul 2024 to Aug 2025
- Enrollment target: 406 to 544
- Study completion date: Jul 2025 to Aug 2026
- Minor Site details revised at 1 of 65 sitesv26
- Minor Site details revised at 2 of 65 sitesv25
- Minor Site details revised at 2 of 65 sitesv23
- Minor Site details revised at 4 of 65 sitesv22
- Minor Site details revised at 4 of 65 sitesv20
- Minor Site details revised at 6 of 65 sitesv19
- Minor Study sites: 64 to 65v18
- Minor Site details revised at 4 of 64 sitesv17
- Minor Site details revised at 1 of 64 sitesv16
- Minor Study sites: 65 to 64v15
- Minor Study sites: 63 to 65v14
- Minor Study sites revised (63)v13
- Minor Study sites: 61 to 63v12
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Arms and interventions
Low-molecular weight heparin (LMWH) or unfractionated heparin (UFH)
Low-molecular weight heparin (LMWH) or unfractionated heparin (UFH) and EkoSonicTM Endovascular System \[ultrasound-facilitated catheter-directed delivery of thrombolytic: 2 mg bolus/catheter + 1 mg/hour/catheter for 7 hours (total of 9 or 18 mg\]
Drugs: Anticoagulation with heparin
Devices: EkoSonicTM Endovascular System
Sites
60 sites in 9 countries
United States 28, Germany 11, Austria 4, France 3, Netherlands 3, Poland 3, Switzerland 3, United Kingdom 3, Ireland 2